SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following its latest update, which showcased substantial revenue growth and accelerating global expansion of its ANKTIVA cancer therapy, sparking community discussion around potential expedited regulatory approvals and a significant short squeeze opportunity amid high after-hours volatility.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is seeing intense trading and sharp declines despite broader energy sector rallies and surging crude oil prices driven by escalating Middle East tensions. The community is fiercely debating whether this extreme volatility stems from active dilution and market manipulation or is a massive shakeout positioning the low-float stock for a potential short squeeze, reminiscent of its historical explosive movements during geopolitical events.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending following its recent earnings report, which delivered a narrow beat and generally in-line guidance, sparking a heated community debate between those who view it as a leading cybersecurity platform poised to benefit from AI and rising geopolitical tensions, and others who contend its valuation remains excessively high despite analyst upgrades.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending following mixed reactions to its Q4 '26 earnings report, which saw a beat on revenue and EPS along with a $400M share repurchase program, yet offered weaker-than-expected FY2027 guidance. The community is divided between those buying the dip, citing AI integration and persistent buyout rumors, and bears concerned about slowing growth and the impact of AI competition on software companies.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a strong earnings beat and robust cash position, yet community discussion is overwhelmingly dominated by frustration over CEO Peter Greenleaf's continued lack of transparency regarding AUR200's clinical trial indications, fueling speculation of an imminent buyout amidst accusations of mismanagement.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics Inc. is trending following its transformative acquisition of Covelya Group, significantly expanding its global footprint in subsea technology and positioning it as a major supplier for defense and commercial sectors. The community is actively discussing potential short-term share dilution from a public offering against robust long-term growth potential and strategic partnerships within the burgeoning underwater robotics sector.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as it achieves new all-time highs on notable trading volume and significant inflows, showcasing strong outperformance against international equities. Community discussion highlights optimism for the ETF as a core long-term holding, reflecting robust U.S. market momentum.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing significant market interest and trading volume amid escalating geopolitical tensions, with the community speculating on its tactical drone systems' role in modern warfare and the potential for increased defense contracts. This surge is further bolstered by analyst optimism and a new partnership with Allen Control Systems to advance counter-drone capabilities, fueling discussions about a potential short squeeze.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as escalating Middle East tensions halt Qatar's LNG production and disrupt the Strait of Hormuz, driving global natural gas prices dramatically higher. This geopolitical "perfect storm," combined with a strong earnings beat and a favorable legal outcome against Shell, positions the company as a key beneficiary, fueling community discussion around potential short squeezes and its undervalued status.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors balance the potential boost to its defense segment from geopolitical tensions with ongoing commercial recovery efforts, amidst community debate over the stock's subdued reaction despite reports of increasing aircraft deliveries and new orders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Summary: Rigel Pharmaceuticals Q4

Rigel Pharmaceuticals (NASDAQ:RIGL) Announces Earnings Results

Rigel Pharmaceuticals (NASDAQ:RIGL - Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported $13.54 earnings per share (EPS) for the quarter, beating...

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

SNY wins Japan orphan drug tag for Waylirz in IgG4-RD and adds regulatory perks as the BTK inhibitor advances in late-stage studies.

A Preview Of Rigel Pharmaceuticals's Earnings

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Investors need to pay close attention to RIGL stock based on the movements in the options market lately.

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Profound Medical (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates

Xencor (XNCR) delivered earnings and revenue surprises of +86.00% and +30.62%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Rigel Pharmaceuticals (NASDAQ:RIGL) Director Walter Moos Sells 4,000 Shares

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) Director Walter Moos sold 4,000 shares of Rigel Pharmaceuticals stock in a transaction on Friday, February 20th. The stock was sold at an...

Walter Moos Sells 4,000 Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) Stock

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) Director Walter Moos sold 4,000 shares of the company's stock in a transaction on Friday, February 20th. The stock was sold at an average...

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?

Rigel (RIGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

$RIGL Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY
• Rigel Pharmaceuticals expects existing capital resources to fund its expenses and capital expenditure requirements through at least the next 12 months from the 10-K filing date.

Stocktwits

Rigel Pharmaceuticals

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY
• Rigel Pharmaceuticals expects existing capital resources to fund its expenses and capital expenditure requirements through at least the next 12 months from the 10-K filing date.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$RIGL Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Software / SaaS

Cybersecurity

Cloud Infrastructure

AI / Semiconductors

Which beaten-down sector are you buying first?

Stocktwits Polls

Traders are reacting to the impressive Q4 2025 earnings, with GAAP EPS skyrocketing 1717.28% YoY to $14.72 and revenues reaching $69.8M, exceeding analyst expectations.

RIGL
Rigel Pharmaceuticals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest RIGL News

RIGLRigel Pharmaceuticals